Direct-to-Patient Research: Piloting a New Approach to Understanding Drug Safety During Pregnancy (original) (raw)

Postmarketing surveillance for drug safety in pregnancy: The Organization of Teratology Information Services Project

Carolyn McCloskey

Birth Defects Research Part A-clinical and Molecular Teratology, 2004

View PDFchevron_right

Risk of Evidence based drug use through pregnancy Risk Caterogy

Dixon Thomas

View PDFchevron_right

Management of drug misuse in pregnancy

Ed Day

Advances in Psychiatric Treatment, 2005

View PDFchevron_right

Prescription drug use in pregnancy: more evidence of safety is needed

Alastair Sutcliffe

The Obstetrician & Gynaecologist, 2012

View PDFchevron_right

Risk perception by healthcare professionals related to drug use during pregnancy: a Swiss survey

Yvonne Meyer

Swiss Medical Weekly, 2014

View PDFchevron_right

Drug utilization and teratogenicity risk categories during pregnancy

Sibel Kalaca

Advances in Therapy, 2007

View PDFchevron_right

Evidence based information on drug use during pregnancy: a survey of community pharmacists in three countries

Ingunn Bjornsdottir

Pharmacy World & Science, 2001

View PDFchevron_right

Protocol for a drugs exposure pregnancy registry for implementation in resource-limited settings

Jan Singlovic, Ushma Mehta

BMC Pregnancy and Childbirth, 2012

View PDFchevron_right

Perception of risk regarding the use of medications and other exposures during pregnancy

Hedvig Nordeng

European Journal of Clinical Pharmacology, 2010

View PDFchevron_right

Measuring prenatal drug exposure

Christi Bergin

Journal of Pediatric Nursing, 2001

View PDFchevron_right

Influences on participant reporting in the World Health Organisation drugs exposure pregnancy registry; a qualitative study

Omar Egesah, Elizabeth Allen, Anthony Mbonye, Ushma Mehta

BMC Health Services Research, 2014

View PDFchevron_right

Drugs of abuse in pregnancy

James Walker

Best Practice & Research Clinical Obstetrics & Gynaecology, 2001

View PDFchevron_right

Collaborative study on drug use in pregnancy: the results of the follow-up 10 years after (Novi Sad Centre)

Ana Sabo

Pharmacoepidemiology and Drug Safety, 2001

View PDFchevron_right

Clinical pharmacology consultation: a better answer to safety issues of drug therapy during pregnancy?

Matea Radačić-aumiler

European Journal of Clinical Pharmacology, 2010

View PDFchevron_right

Risk Perception of Family Medicine Residents Regarding Drug Exposure in Pregnancy

Yusuf Kaplan

Turkish Journal of Family Medicine & Primary Care, 2015

View PDFchevron_right

Surveillance of adverse fetal effects of medications (SAFE-Med): Findings from the International Clearinghouse of Birth Defects Surveillance and Research

Elisabeth Robert-gnansia

Reproductive Toxicology, 2010

View PDFchevron_right

Medication Exposure in Pregnancy Risk Evaluation Program

Pamala Pawloski

Maternal and Child Health Journal, 2012

View PDFchevron_right

DRUGS IN PREGNANCY

Asian Journal of Pharmaceutical and Clinical Research Journal

Asian Journal of Pharmaceutical and Clinical Research, 2020

View PDFchevron_right

Drugs of Dependency: The Pregnant Woman and Her Infant

mohamed abdellatif

International Journal of Pediatrics, 2011

View PDFchevron_right

Drug Utilization Pattern and Potential Teratogenicity Risk among Pregnant Women Visiting Antenatal Clinic: The Case of a Primary Hospital

Dereje Kebebe

Indian Journal of Pharmacy Practice, 2015

View PDFchevron_right

Prescription drug use in pregnancy

Abraham Morse

American Journal of Obstetrics and Gynecology, 2004

View PDFchevron_right

Assessment of Drug Usage Pattern during Pregnancy at a Tertiary Care Teaching Hospital

Dr.Reshma Banu

International Journal of Medicine and Public Health, 2016

View PDFchevron_right

The status of pharmacometrics in pregnancy: highlights from the 3 rd American conference on pharmacometrics

Mary Hebert, Donald Mattison

British Journal of Clinical Pharmacology, 2012

View PDFchevron_right